InertSearch (Application Library)
Index
Application
LC
Micro GC
Document No. Index
LB900 - 999 of Application List
| No. | Description | Column |
|---|---|---|
| LB900 | Analysis of Fesoterodine Fumarate | InertSustain C8 |
| LB901 | Analysis of Saxagliptin | InertSustain C18 |
| LB902 | Analysis of Saxagliptin | InertSustain C18 |
| LB903 | Analysis of Perospirone hydrochloride | InertSustain C18 |
| LB904 | Analysis of Celecoxib | Inertsil Ph-3 |
| LB905 | Analysis of Aripiprazole | InertSustain C18 |
| LB906 | Analysis of Aripiprazole | InertSustain C18 |
| LB907 | Analysis of Aripiprazole | InertSustain C18 |
| LB908 | Analysis of Fatty acids (C1-C18) | InertSustain AQ-C18 |
| LB909 | Analysis of Fatty acids (C18-C26) | InertSustain AQ-C18 |
| LB910 | Analysis of Fatty acids (C18-C26) | InertSustain AQ-C18 |
| LB911 | Analysis of Metformin Hydrochloride | Inertsil WP300 C18 |
| LB912 | Analysis of Metformin Hydrochloride | Inertsil WP300 C18 |
| LB913 | Analysis of Saxagliptin | InertSustain C18 |
| LB914 | Analysis of Saxagliptin | InertSustain C18 |
| LB915 | Analysis of Metformin Hydrochloride | InertSustain C18 |
| LB916 | Analysis of Metformin Hydrochloride | InertSustain C18 |
| LB917 | Analysis of 130 Pestisides | InertSustain C18 |
| LB918 | Analysis of d-α-Tocopheryl Acetate | InertSustain C18 |
| LB919 | Analysis of Pitavastatin Calcium | InertCore Plus C18 |
| LB920 | Analysis of Triphenylphosphine oxide | InertSustain C18 |
| LB921 | Analysis of 4 Drugs | Inertsil ODS-4 |
| LB922 | Analysis of 4 Drugs | InertSustai AQ-C18 |
| LB922 | Analysis of 4 Drugs | InertSustain AQ-C18 |
| LB923 | Analysis of Organic acids | InertSphere FA-1 |
| LB924 | Analysis of Acyclovir | InertSustain Cyano |
| LB925 | Analysis of Acyclovir | InertSustain Cyano |
| LB926 | Analysis of Piperacillin Sodium | Inertsil WP300 C18 |
| LB927 | Analysis of Blonanserin | InertSustain C18 |
| LB928 | Analysis of Blonanserin | InertSustain C18 |
| LB929 | Analysis of Blonanserin | InertSustain C18 |
| LB930 | Analysis of Blonanserin | InertSustain C18 |
| LB931 | Analysis of Acyclovir | Inertsil ODS-3 |
| LB932 | Analysis of 13 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) | Inertsil ODS-HL |
| LB933 | Analysis of Diclofenac sodium | Inertsil WP300 C18 |
| LB934 | Analysis of Methylpyrazines | InertSustain C18 |
| LB935 | Analysis of Febuxostat | InertSustain AQ-C18 |
| LB936 | Analysis of Febuxostat | InertSustain C30 |
| LB937 | Analysis of Febuxostat | Inertsil ODS-4 |
| LB938 | Analysis of Galantamine | InertSustain C18 |
| LB939 | Analysis of Potassium sucrose octasulfate | Inertsil NH2 |
| LB940 | Analysis of DL-Malic acid | InertSustain C18 |
| LB941 | Analysis of Fumaric acid | Inertsil ODS-4 |
| LB942 | Analysis of Maleic acid | Inertsil ODS-4 |
| LB943 | Analysis of Amikacin | InertSustainSwift C18 |
| LB944 | Analysis of Amikacin sulfate | InertSustainSwift C18 |
| LB945 | Analysis of Glacial Acetic Acid | InertSustain AQ-C18 |
| LB946 | Analysis of Glacial Acetic Acid | InertSustain AQ-C18 |
| LB947 | Analysis of Glacial Acetic Acid | InertSustain AQ-C18 |
| LB948 | Analysis of Omeprazole | Inertsil C8-3 |
| LB949 | Analysis of Panose | Inertsustain NH2 |
| LB950 | Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) | InertSustain C18 |
| LB951 | Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) | InertSustain C18 |
| LB952 | Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) | InertSustain C18 |
| LB953 | Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) | InertSustain Cyano |
| LB954 | Analysis of Difluoroacetic acid and Trifluoroacetic acid | InertSustain AQ-C18 |
| LB955 | Analysis of Difluoroacetic acid and Trifluoroacetic acid | InertSustain AX-C18 |
| LB956 | Analysis of Sumatriptan succinate and Naproxen Sodium | Insertsil Ph-3 |
| LB957 | Analysis of Amino acids | InertSphere Sugar-1 |
| LB958 | Analysis of Methyltestosterone and Progesterone | Insertsil WP300 C18 |
| LB959 | Analysis of Food Dyes | InertSustainSwift C18 |
| LB960 | Analysis of Lidocaine | Insertsil WP300 C18 |
| LB961 | Analysis of Lidocaine | Insertsil WP300 C18 |
| LB962 | Analysis of β-carotene | InertSustainSwift C18 |
| LB963 | Analysis of Citric acid, Tartaric acid, Malic acid, Succinic acid, Lactic acid, Fumaric acid, Acetic acid and their salts | InertSphere FA-1 |
| LB964 | Analysis of Citric acid, Tartaric acid, Malic acid, Succinic acid, Lactic acid, Fumaric acid, Acetic acid and their salts | InertSphere FA-1 |
| LB965 | Analysis of Nicardipine Hydrochloride | InertSustain C8 |
| LB967 | Analysis of Difluoroacetic acid and Trifluoroacetic acid | InertSustain AQ-C18 |
| LB968 | Analysis of Acyclovir | Inertsil WP300 C18 |
| LB969 | Analysis of Acyclovir | InertSustainSwift C18 |
| LB970 | Analysis of Acyclovir | InertSustain C18 |
| LB971 | Analysis of Acyclovir | InertSustain C18 |
| LB972 | Analysis of Acyclovir | InertSustain C18 |
| LB973 | Analysis of Dapagliflozin propandiol | InertSustain C18 |
| LB974 | Analysis of Dapagliflozin propandiol | InertSustain C18 |
| LB975 | Analysis of Dapagliflozin propandiol | InertSustain C18 |
| LB976 | Analysis of Dapagliflozin propandiol | InertSustain C18 |
| LB977 | Analysis of Dapagliflozin propandiol | InertSustain AQ-C18 |
| LB978 | Analysis of Hydrochlorothiazide | InertSustain AQ-C18 |
| LB979 | Analysis of Desloratadine | InertSustain Cyano |
| LB980 | Analysis of Desloratadine | InertSustain AQ-C18 |
| LB981 | Analysis of Ofloxacin | Inertsil WP300 C18 |
| LB982 | Analysis of Ofloxacin | InertSustain C18 |
| LB983 | Analysis of Lornoxicam | Inertsil ODS-4 |
| LB984 | Analysis of Sumatriptan | InertSustain AQ-C18 |
| LB985 | Analysis of Sumatriptan | Inertsil ODS-3 |
| LB986 | Analysis of Ganciclovir | Inertsil ODS-3 |
| LB987 | Analysis of Xylazine | Inertsil WP300 C18 |
| LB988 | Analysis of Xylazine | InertSustainSwift C8 |
| LB989 | Analysis of Xylazine | InertSustain C18 |
| LB990 | Analysis of Xylazine | Inertsil WP300 C18 |
| LB991 | Analysis of Progestrone and Methyltestrone | Inertsil WP300 C18 |
| LB992 | Analysis of Xylitol, D-Sorbitol and D-Mannitol | InertSphere Sugar-2 |
| LB993 | Analysis of Theophylline | InertSustainSwift C8 |
| LB994 | Analysis of Mesalamine | InertSustain C8 |
| LB995 | Analysis of Mesalamine | InertSustain C8 |
| LB996 | Analysis of Mesalamine | InertSustain C8 |
| LB997 | Analysis of Mesalamine | InertSustain C8 |
| LB998 | Analysis of Dextrose | InertSphere Sugar-2 |
| LB999 | Analysis of Monosaccharides and Disaccharides | InertSphere Sugar-1 |


















